Transcranial Direct Current Stimulation - Tobacco Use Disorder
NCT03691805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2020-12-30
Summary
This study aims to detect how transcranial direct current stimulation (tDCS) affects smokers' inhibitory control, craving and consumption of tobacco goods.
Conditions
- Tobacco Use Disorder
Interventions
- DEVICE
-
tDCS
The participants will receive anodal tDCS (transcranial direct current stimulation) of the right dorsolateral prefrontal cortex for 20 minutes on five consecutive days.
- DEVICE
-
Sham tDCS
The participants will receive sham tDCS (transcranial direct current stimulation) of the dorsolateral prefrontal cortex for 20 minutes on five consecutive days.
Sponsors & Collaborators
-
Central Institute of Mental Health, Mannheim
lead OTHER
Principal Investigators
-
Sabine Vollstädt-Klein · ZI Mannheim
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-15
- Primary Completion
- 2020-02-18
- Completion
- 2020-02-18
Countries
- Germany
Study Locations
More Related Trials
-
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
NCT03960138 ·Status: COMPLETED ·Phase: NA
-
The Use of tDCS for Vaping Reduction
NCT06885606 ·Status: RECRUITING ·Phase: NA
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
NCT05796791 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TNS for Treating Nicotine Craving
NCT02178852 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Nicotine on Brain Reward Pathways
NCT02346539 ·Status: COMPLETED ·Phase: PHASE1
-
Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers
NCT02590640 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving
NCT00208858 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated dTMS Smoking Cessation
NCT07292883 ·Status: RECRUITING ·Phase: PHASE2
-
Electronic Cigarettes and Reactivity to Smoking Cues
NCT01782599 ·Status: RECRUITING ·Phase: NA
-
Effects of Nicotine on Brain Activity as Measured by fMRI
NCT01037153 ·Status: COMPLETED
-
The Effects of Sedatives on Tobacco Use Disorder
NCT03813121 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Temporal Interference Methods for Addiction Treatment
NCT07210268 ·Status: RECRUITING ·Phase: NA
-
Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
NCT00133757 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging in Tobacco Smokers During a Quit Attempt
NCT04055467 ·Status: COMPLETED ·Phase: PHASE1
-
Acute and Chronic Nicotine Modulation of Reinforcement Learning
NCT01830842 ·Status: COMPLETED ·Phase: NA
-
The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers
NCT00267813 ·Status: COMPLETED ·Phase: NA
-
Bupropion and Cigarette-Related Cues in Smokers
NCT03920319 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease
NCT00873392 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control
NCT00830739 ·Status: COMPLETED
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
NCT00802412 ·Status: COMPLETED ·Phase: PHASE2
-
Medicinal Nicotine for Preventing Cue Induced Craving
NCT02347605 ·Status: COMPLETED ·Phase: NA
-
Nicotine Patch Pretreatment for Smoking Cessation in PTSD
NCT00625131 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
NCT03083353 ·Status: COMPLETED ·Phase: EARLY_PHASE1